HUP0204123A2 - Készítmények meghűlés és influenzaszerű tünetek megelőzésére és kezelésére, előállításuk és alkalmazásuk - Google Patents

Készítmények meghűlés és influenzaszerű tünetek megelőzésére és kezelésére, előállításuk és alkalmazásuk

Info

Publication number
HUP0204123A2
HUP0204123A2 HU0204123A HUP0204123A HUP0204123A2 HU P0204123 A2 HUP0204123 A2 HU P0204123A2 HU 0204123 A HU0204123 A HU 0204123A HU P0204123 A HUP0204123 A HU P0204123A HU P0204123 A2 HUP0204123 A2 HU P0204123A2
Authority
HU
Hungary
Prior art keywords
prevention
treatment
preparation
influenza
symptoms
Prior art date
Application number
HU0204123A
Other languages
English (en)
Inventor
Kimberly Ann Biedermann
Simon Phillip King
Jeffrey Michael Morgan
Paul John Rennie
Original Assignee
The Procter And Gamble Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter And Gamble Co. filed Critical The Procter And Gamble Co.
Publication of HUP0204123A2 publication Critical patent/HUP0204123A2/hu
Publication of HUP0204123A3 publication Critical patent/HUP0204123A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • D—TEXTILES; PAPER
    • D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
    • D21H21/00—Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties
    • D21H21/14—Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties characterised by function or properties in or on the paper
    • D21H21/36—Biocidal agents, e.g. fungicidal, bactericidal, insecticidal agents
    • D—TEXTILES; PAPER
    • D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
    • D21H27/00—Special paper not otherwise provided for, e.g. made by multi-step processes
    • D21H27/30—Multi-ply
    • D21H27/32—Multi-ply with materials applied between the sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pest Control & Pesticides (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány tárgya készítmény meghűlés és influenzavírusok okoztafertőzések megelőzésére és kezelésére, ennek előállítása, valamintalkalmazása. A készítmény piroglutaminsavat (PCA) és egy szerves savattartalmaz, ahol a piroglutaminsav és a szerves sav kombinációja azorrüreg szövetén 3,5-5,5 felületi pH-értéket biztosít. A készítménytmeghűlés és influenzavírusok megelőzésére és kezelésére az orrlyukakbavagy az orrkagylóba fecskendezve adják be. Ó
HU0204123A 1999-10-19 2000-10-19 Compositions for prevention and treatment of cold and influenza-like symptoms, their preparation and use HUP0204123A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42113199A 1999-10-19 1999-10-19
PCT/US2000/028856 WO2001028556A2 (en) 1999-10-19 2000-10-19 Compositions for prevention and treatment of cold and influenza-like symptoms and their methods of use

Publications (2)

Publication Number Publication Date
HUP0204123A2 true HUP0204123A2 (hu) 2003-04-28
HUP0204123A3 HUP0204123A3 (en) 2003-05-28

Family

ID=23669286

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0204123A HUP0204123A3 (en) 1999-10-19 2000-10-19 Compositions for prevention and treatment of cold and influenza-like symptoms, their preparation and use

Country Status (21)

Country Link
EP (2) EP1242073B1 (hu)
JP (2) JP2003512325A (hu)
KR (2) KR20020042729A (hu)
CN (3) CN1411372A (hu)
AT (1) ATE276749T1 (hu)
AU (2) AU8029700A (hu)
BR (1) BR0014778A (hu)
CA (2) CA2388802C (hu)
CZ (1) CZ20021374A3 (hu)
DE (1) DE60014163T2 (hu)
ES (1) ES2223601T3 (hu)
HK (1) HK1050475A1 (hu)
HU (1) HUP0204123A3 (hu)
MX (1) MXPA02003882A (hu)
NO (1) NO20021830L (hu)
NZ (1) NZ518117A (hu)
PL (1) PL199782B1 (hu)
RU (1) RU2228177C2 (hu)
TR (1) TR200201048T2 (hu)
WO (2) WO2001028556A2 (hu)
ZA (1) ZA200202475B (hu)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
WO2001053444A1 (en) * 2000-01-20 2001-07-26 The Procter & Gamble Company Antimicrobial compositions
US20020172656A1 (en) 2000-01-20 2002-11-21 Biedermann Kimberly Ann Cleansing compositions
DE10065045A1 (de) * 2000-12-23 2002-07-04 Beiersdorf Ag W/O-Emulsionen mit einem Gehalt an einem oder mehreren Ammoniumacryloyldimethyltaurat/Vinylpyrrolidoncopolymeren
JP4681132B2 (ja) * 2001-01-29 2011-05-11 味の素株式会社 一酸化窒素合成酵素産生促進剤および化粧料若しくは医薬組成物
TWI228420B (en) * 2001-05-30 2005-03-01 Smithkline Beecham Pharma Gmbh Novel vaccine composition
JP4318899B2 (ja) * 2001-08-27 2009-08-26 第一三共ヘルスケア株式会社 抗感冒剤
JP2009132734A (ja) * 2001-08-27 2009-06-18 Daiichi Sankyo Healthcare Co Ltd 抗感冒剤
DE10144235B4 (de) * 2001-09-08 2004-08-19 Beiersdorf Ag W/S-Emulsionen und deren Verwendung
US20030118620A1 (en) * 2001-09-12 2003-06-26 Unilever Home & Personal Care Usa, Division Of Conopco Inc. Thickener system for cosmetic compositions
US6806213B2 (en) 2001-12-20 2004-10-19 Kimberly-Clark Worldwide, Inc. Disposable wash cloth and method of using
ES2327508T3 (es) 2002-03-12 2009-10-30 GALDERMA RESEARCH & DEVELOPMENT Empleo de adapaleno para el tratamiento de trastornos dermatologicos.
WO2004000016A2 (en) * 2002-06-21 2003-12-31 The Procter & Gamble Company Antimicrobial compositions, products and methods employing same
US7569530B1 (en) 2003-06-20 2009-08-04 The Procter & Gamble Company Antimicrobial compositions, products and methods employing same
WO2004064867A1 (en) * 2003-01-13 2004-08-05 The Procter & Gamble Company Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers
WO2004112773A1 (fr) * 2003-04-24 2004-12-29 Shin-Jen Shiao Compositions pharmaceutiques utilisees pour le traitement de maladie immune et amelioration
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
WO2005027893A1 (ja) * 2003-09-19 2005-03-31 Otsuka Pharmaceutical Co., Ltd. ヒトβディフェンシン分泌促進剤
US20050271711A1 (en) * 2004-04-26 2005-12-08 The Procter & Gamble Company Therapeutic antimicrobial compositions and methods
CA2569155A1 (en) 2004-06-02 2005-12-15 Sri International Formulations comprising a capsaicinoid a local anesthetic and/or an antipruritic agent for the treatment of pain
DE102004041333A1 (de) * 2004-08-20 2006-03-09 Dental-Kosmetik Gmbh & Co. Kg Zahngel
US9028852B2 (en) 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US8198326B2 (en) * 2004-09-07 2012-06-12 3M Innovative Properties Company Phenolic antiseptic compositions and methods of use
DE602005009307D1 (de) * 2004-10-13 2008-10-09 Procter & Gamble Vorrichtung zur Abgabe einer antimikrobiellen Zusammensetzung
MX2007010906A (es) 2005-03-10 2007-12-05 3M Innovative Properties Co Metodos para reducir la contaminacion microbiana.
BRPI0608691A2 (pt) 2005-03-10 2010-12-07 3M Innovative Properties Co composição antimicrobiana, e, métodos para matar ou inativar microorganismos em tecido da mucosa de um mamìfero, para tratar uma lesão ou ferimento infectado, para descolonização de microorganismos, para proporcionar eficácia antimicrobiana residual sobre uma superfìcie e para tratar uma condição
ITMI20052077A1 (it) * 2005-10-31 2007-05-01 Roda S R L Agente batteriostatica e-o battericida per preparazioni cosmetiche e-o dermofarmaceutiche e preparazioni contenenti questo agente
US20070110676A1 (en) * 2005-11-17 2007-05-17 The Procter & Gamble Company Compositions useful for prevention and treatment of common cold and influenza-like symptoms
DE102007006122A1 (de) * 2007-02-02 2008-08-07 Krewel Meuselbach Gmbh Cistusextrakte
CZ2007173A3 (cs) * 2007-03-06 2008-04-30 Ecoton S. R. O. Dezinfekcní prostredek
GB2456528B (en) * 2008-01-16 2012-08-22 Pangaea Lab Ltd Antioxidant for use in cosmetic, medicated and pharmaceutical compositions
ATE524160T1 (de) * 2008-02-14 2011-09-15 Kpss Kao Gmbh Haarpflegemittel enthaltend pca und pca-ester
AU2009317951B2 (en) * 2008-10-30 2014-07-31 Cleanwell, Llc Antimicrobial foamable soaps
CA2977492C (en) * 2008-11-04 2019-03-12 Vymedic, Llc Antiviral supplement formulations
JP5935689B2 (ja) * 2010-02-16 2016-06-15 味の素株式会社 ピロリドンカルボン酸またはその塩の製造方法
JP2013139391A (ja) * 2010-04-09 2013-07-18 Hokkaido Univ ウイルス感染抑制および／または感染症治療剤
US20110305651A1 (en) * 2010-06-15 2011-12-15 Conopco, Inc. D/B/A Unilever Sunless tanning compositions with nucleophile functionalized sulfonic acids
IT1400721B1 (it) * 2010-07-07 2013-06-28 Baldacci Lab Spa Composizioni a base di acido pirrolidoncarbossilico (pca) e sali metallici.
US8821839B2 (en) 2010-10-22 2014-09-02 Conopco, Inc. Compositions and methods for imparting a sunless tan with a vicinal diamine
EP2760546B1 (en) 2011-09-26 2017-09-20 Unilever Plc. Hair composition
JP6100510B2 (ja) * 2011-11-16 2017-03-22 第一三共ヘルスケア株式会社 抗感冒剤
US8961942B2 (en) 2011-12-13 2015-02-24 Conopco, Inc. Sunless tanning compositions with adjuvants comprising sulfur comprising moieties
CN102560036A (zh) * 2012-01-17 2012-07-11 杭州百木表面技术有限公司 铜带退火防粘剂
CZ303941B6 (cs) * 2012-04-24 2013-07-03 Farmak Moravia, A.S. Dezinfekcní prípravek, jeho pouzití a zpusob dezinfekce
MY184460A (en) * 2012-11-08 2021-04-01 Lion Corp Oral composition and oral active oxygen scavenger
US20150030862A1 (en) * 2013-07-26 2015-01-29 United State Gypsum Company Mold-resistant paper and gypsum panel, antimicrobial paper coating and related methods
WO2015040642A1 (en) * 2013-09-19 2015-03-26 B.B.S. S.P.A. Process for the preparation of an antibacterial polymer material for food application
RU2555358C1 (ru) * 2014-06-06 2015-07-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" (ФГБОУ ВПО "КубГТУ") Гель для душа
RU2577697C2 (ru) * 2014-12-26 2016-03-20 Анатолий Тимофеевич Корабельников Средство для избавления от полипов в пазухах носа и для предотвращения их повторного нарастания, а также способ его применения
JP6579529B2 (ja) 2015-01-23 2019-09-25 バイオシディウム アイピー ホルコ カンパニー 抗菌組成物
RU2626829C2 (ru) * 2015-11-02 2017-08-02 Анатолий Тимофеевич Корабельников Средство для лечения полипов в пазухах носа и для предотвращения их повторного нарастания, а также способ его применения
JP6465820B2 (ja) * 2016-01-15 2019-02-06 安井 敦司 抗菌・抗ウイルス性組成物およびこれを含む潤滑剤
JP6689613B2 (ja) * 2016-01-29 2020-04-28 株式会社Ｃｓｌ 繊維用抗菌・抗ウイルス性組成物および繊維製品
JP6317798B2 (ja) * 2016-10-19 2018-04-25 小林製薬株式会社 インフルエンザウイルスの感染抑制剤
CA3066044A1 (en) * 2017-06-05 2018-12-13 Verdesian Life Sciences U.S., Llc Combination of pyroglutamic acid and a strobilurin fungicide for improved plant health effects
CN107573271B (zh) * 2017-08-11 2020-01-14 吴文君 一种氨基酸类化合物及其杀菌组合物与应用
CN107467029B (zh) * 2017-08-11 2021-02-19 西北农林科技大学 一种氨基酸类农用组合物
US20190070219A1 (en) * 2017-09-06 2019-03-07 King Bio, Inc. Homeopathic Nasal Gel, Swab, and Spray Formulations
KR20190045050A (ko) 2018-09-07 2019-05-02 류형준 감기 개선 식품조성물
EP3691449A1 (en) 2018-12-28 2020-08-12 Diversey, Inc. Synergistic disinfectant compositions having enhanced antimicrobial efficacy and stability, and methods of using the same
WO2021191297A1 (en) * 2020-03-25 2021-09-30 Universität Basel Virucidal hand cream formulation
CN111467338B (zh) * 2020-04-07 2021-04-23 中国科学院深圳先进技术研究院 焦谷氨酸在制备预防和治疗抗新冠肺炎新型冠状病毒的药物中的应用
JPWO2022044582A1 (hu) * 2020-08-28 2022-03-03
CN112710651B (zh) * 2021-01-20 2023-10-13 浙江夸克生物科技有限公司 一种脂蛋白相关磷脂酶a2的测定试剂盒
KR20220110669A (ko) 2021-01-31 2022-08-09 (주)예스킨 코비드-19 항바이러스제
KR20220110655A (ko) 2021-01-31 2022-08-09 (주)예스킨 코비드-19 항바이러스제 및 항바이러스제용 어주번트
US20230014524A1 (en) * 2021-06-30 2023-01-19 The Procter & Gamble Company Cleansing composition with pyrrolidone carboxylic acid
CN113956466B (zh) * 2021-11-05 2023-04-25 首都医科大学附属北京口腔医院 钛修饰双亲性高分子材料及其制备方法和其在制备口腔材料用修饰外泌体中的用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767788A (en) * 1978-08-14 1988-08-30 Sterling Drug Inc. Glutaric acid virucidal processes and compositions
JPS572690A (en) * 1980-06-05 1982-01-08 Kyowa Hakko Kogyo Co Ltd Preparation of l-proline by fermentation method
DE3431727A1 (de) * 1984-08-29 1986-03-13 Robugen GmbH Pharmazeutische Fabrik, 7300 Esslingen Nasenspray gegen schnupfen und grippe mit einem gehalt an zinkglukonat
US4738847A (en) * 1985-01-14 1988-04-19 Kimberly-Clark Corporation Multi-ply virucidal product
JPS6422804A (en) * 1987-07-16 1989-01-25 Kanebo Ltd Sterilizing solution composition for wet tissue
US5244880A (en) * 1988-11-02 1993-09-14 Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Stable aqueous solutions of prymicin and pharmaceutical and cosmetic compositions containing these solutions
CA2003808C (en) * 1988-11-28 1999-11-09 Eugene Joseph Sehm Crosslinked polyacrylic acid
IE892257A1 (en) * 1989-07-13 1991-02-13 Elan Corp Anti-infective agent, process for its preparation and its¹use in therapy
FR2656523B1 (fr) * 1989-12-29 1992-05-07 Biorga Sa Labo Compositions pour l'usage cosmetique et/ou dermatologique, comprenant des pidolates metalliques.
CH683671A5 (it) * 1992-03-30 1994-04-29 Golgi Sa Uso topico di glicerofosfolipidi deacilati.
EP0662814B1 (de) * 1992-09-29 1996-07-17 Henkel Kommanditgesellschaft auf Aktien Haarbehandlungsmittel
FR2697161B1 (fr) * 1992-10-26 1995-01-13 Jouvance Daniel Produit cosmétique à potentiel redox stabilisé.
US5508282C1 (en) * 1993-05-17 2001-01-23 Tulin Silver Jeffrey Composition and method for treating acute or chronic rhinosinusitis
JPH08133911A (ja) * 1994-11-04 1996-05-28 Senju Pharmaceut Co Ltd 抗菌組成物
DE19625982A1 (de) * 1996-06-28 1998-01-02 Wella Ag Kosmetisches Mittel zur Haarbehandlung mit Dendrimeren
US5942508A (en) * 1997-02-04 1999-08-24 Senju Pharmaceutical Co., Ltd. Method for solubilizing pyridonecarboxylic acid solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid

Also Published As

Publication number Publication date
EP1225887A2 (en) 2002-07-31
NZ518117A (en) 2004-03-26
JP2003512323A (ja) 2003-04-02
WO2001028552A3 (en) 2001-06-14
CN101711761A (zh) 2010-05-26
CA2382985A1 (en) 2001-04-26
KR20020042729A (ko) 2002-06-05
MXPA02003882A (es) 2002-10-23
AU1214701A (en) 2001-04-30
HK1050475A1 (zh) 2003-06-27
EP1242073B1 (en) 2004-09-22
NO20021830D0 (no) 2002-04-18
CA2388802C (en) 2007-09-11
ATE276749T1 (de) 2004-10-15
HUP0204123A3 (en) 2003-05-28
AU8029700A (en) 2001-04-30
KR20020038945A (ko) 2002-05-24
JP2003512325A (ja) 2003-04-02
EP1242073A2 (en) 2002-09-25
ES2223601T3 (es) 2005-03-01
RU2002113092A (ru) 2004-02-20
PL355291A1 (en) 2004-04-05
RU2228177C2 (ru) 2004-05-10
DE60014163T2 (de) 2005-10-06
AU777549B2 (en) 2004-10-21
CZ20021374A3 (cs) 2002-08-14
WO2001028556A3 (en) 2001-10-11
NO20021830L (no) 2002-04-18
PL199782B1 (pl) 2008-10-31
CN1411372A (zh) 2003-04-16
CN1379667A (zh) 2002-11-13
BR0014778A (pt) 2002-07-16
CA2388802A1 (en) 2001-04-26
WO2001028556A2 (en) 2001-04-26
TR200201048T2 (tr) 2002-08-21
ZA200202475B (en) 2003-06-27
DE60014163D1 (de) 2004-10-28
WO2001028552A2 (en) 2001-04-26

Similar Documents

Publication Publication Date Title
HUP0204123A2 (hu) Készítmények meghűlés és influenzaszerű tünetek megelőzésére és kezelésére, előállításuk és alkalmazásuk
HUP0301452A2 (hu) Fotokemoterápiás szert és mukoadhéziós szert tartalmazó gyógyszerkészítmény és alkalmazása
NO20053855D0 (no) 1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer.
HUP0301281A2 (hu) Új gyógyászati készítmény
HUP0104709A2 (hu) Eritropoietin vagy eritropoietrinszármazékok alkalmazása agyi iszkémiák kezelésére használható gyógyszer előállítására
HUP0303996A2 (hu) Vakcinakészítmények
PA8469401A1 (es) Derivados biciclicos del acido hidroxamico
HUP0302636A2 (hu) Hasított burkolt víruskészítmény
DOP2002000429A (es) Imidazotriazinas
PL375621A1 (en) Pharmaceutical compositions comprising flavonoids and menthol
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
UY27993A1 (es) Derivados de 4-pirrolidino-fenil-bencil eter
HUP0103922A2 (hu) Pramipexolt és egy további antidepresszánst tartalmazó depresszióellenes hatású szer
BR0209845A (pt) Formas de dosagem de oxcarbazepina e processo para a preparação das mesmas
DE60312736D1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
HUP0500039A2 (hu) Vakcina és eljárás mozgatóneuron-betegségek kezelésére
DE60132851D1 (de) Arzneimittel zur Vorbeugung, Erleichterung oder Behandlung von Hypertension
HUP0300559A2 (hu) A trombopoietin receptort moduláló peptidek
BR0314129A (pt) Formulações de liberação modificadas de oxcarbazepina e derivados destas
DE60139783D1 (de) Gen und pflanzenextrakte, wirksam zur behandlung und prävention von chlamydieninfektionen
EA200600603A1 (ru) Оральная система доставки лекарственного препарата
HUP0203740A2 (en) Food product and process
HUP0202931A2 (hu) Egy gyógyszerészetileg hatásos összetétel és a beadására szolgáló készülék
HUP0402381A2 (hu) A monohidroxi-karbamazepin alkalmazása hangulati és a figyelemmel kapcsolatos rendellenességek és idegfájdalom kezelésére alkalmas gyógyszer előállítására
HUP0302738A2 (hu) SARP-1 alkalmazása scleroderma kezelésére és megelőzésére